Pharmacotherapy of Gastrointestinal Inflammation

Softcover Nachdruck of the original 1. Auflage 2004
ISBN: 978-3-0348-9625-2
Verlag: Birkhäuser Basel

Buch, Englisch, 146 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 254 g

Reihe: Progress in Inflammation Research

In recent years, the area of pharmacotherapy of GI inflammation has witnessed important progress, with new drugs and therapeutic approaches being introduced. The volume reviews the pharmacotherapy of selected gastrointestinal inflammatory conditions chosen on the basis of their clinical importance and/or the areas where important and exciting progress has been made recently. Besides discussing current pharmacotherapy to treat the most important GI inflammation conditions, the book also indicates possible future therapeutic avenues likely to become available in a few years.
The book is of interest to various sectors of the scientific community ranging from clinicians to pharmacologists and from biochemists to microbiologists, who will find it a useful tool for their clinical practice and research activity.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Guglietta, Antonio

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Medizinische Mikrobiologie & Virologie
• Naturwissenschaften Biowissenschaften Zellbiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie Gastrointestinale & Colorectale Chirurgie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie

Inhaltsverzeichnis

List of contributors.- Preface.- Pharmacotherapy of Helicobacter pylori-associated gastritis.- Pharmacotherapy of inflammatory bowel disease: novel therapeutic approaches.- Current and future therapy of chronic hepatitis.- Treatment and prevention of antibiotic associated colitis.- Nitric oxide-donating aspirins spare the gastrointestinal (GI) system and improve the treatment of inflammation related GI and cardiovascular pathologies.- Oral tolerance for treatment of GI inflammation.